Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

943 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
Joly P, Roujeau JC, Benichou J, Picard C, Dreno B, Delaporte E, Vaillant L, D'Incan M, Plantin P, Bedane C, Young P, Bernard P; Bullous Diseases French Study Group. Joly P, et al. N Engl J Med. 2002 Jan 31;346(5):321-7. doi: 10.1056/NEJMoa011592. N Engl J Med. 2002. PMID: 11821508 Free article. Clinical Trial.
Paraneoplastic pemphigus is associated with the DRB1*03 allele.
Martel P, Loiseau P, Joly P, Busson M, Lepage V, Mouquet H, Courville P, Flageul B, Charron D, Musette P, Gilbert D, Tron F. Martel P, et al. Among authors: joly p. J Autoimmun. 2003 Feb;20(1):91-5. doi: 10.1016/s0896-8411(02)00092-6. J Autoimmun. 2003. PMID: 12604316
[Bullous pemphigoid].
de Quatrebarbes J, Joly P. de Quatrebarbes J, et al. Among authors: joly p. Rev Prat. 2005 Jun 15;55(11):1165-8. Rev Prat. 2005. PMID: 16164060 Review. French.
Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J, Estève E, Bagot M, Bernard P, Beylot-Barry M, Delaunay M, D'Incan M, Souteyrand P, Vaillant L, Cordel N, Courville P, Joly P. de Quatrebarbes J, et al. Among authors: joly p. Arch Dermatol. 2005 Sep;141(9):1117-20. doi: 10.1001/archderm.141.9.1117. Arch Dermatol. 2005. PMID: 16172308 Clinical Trial.
Rituximab for pemphigus vulgaris.
Joly P, D'Incan M, Musette P. Joly P, et al. N Engl J Med. 2007 Feb 1;356(5):521; author reply 521-2. doi: 10.1056/NEJMc063290. N Engl J Med. 2007. PMID: 17267915 No abstract available.
A single cycle of rituximab for the treatment of severe pemphigus.
Joly P, Mouquet H, Roujeau JC, D'Incan M, Gilbert D, Jacquot S, Gougeon ML, Bedane C, Muller R, Dreno B, Doutre MS, Delaporte E, Pauwels C, Franck N, Caux F, Picard C, Tancrede-Bohin E, Bernard P, Tron F, Hertl M, Musette P. Joly P, et al. N Engl J Med. 2007 Aug 9;357(6):545-52. doi: 10.1056/NEJMoa067752. N Engl J Med. 2007. PMID: 17687130 Free article. Clinical Trial.
Chronic eczematous eruptions of the elderly are associated with chronic exposure to calcium channel blockers: results from a case-control study.
Joly P, Benoit-Corven C, Baricault S, Lambert A, Hellot MF, Josset V, Barbaud A, Courville P, Delaporte E, Collet E, Carvalho P, Modeste-Duval AB, Lacour JP, L'Anthoën-Arditi MH, Thuillez C, Benichou J. Joly P, et al. J Invest Dermatol. 2007 Dec;127(12):2766-71. doi: 10.1038/sj.jid.5701018. Epub 2007 Aug 23. J Invest Dermatol. 2007. PMID: 17713574 Free article.
Neurological disorders in patients with bullous pemphigoid.
Cordel N, Chosidow O, Hellot MF, Delaporte E, Lok C, Vaillant L, Bernard P, D'Incan M, Roujeau JC, Joly P; French Study Group of Bullous Diseases. Cordel N, et al. Among authors: joly p. Dermatology. 2007;215(3):187-91. doi: 10.1159/000106574. Dermatology. 2007. PMID: 17823513
943 results